When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

People living with autoimmune diseases face nearly twice the risk of developing persistent mental health disorders like depression, anxiety, and bipolar disorder, according to a massive UK-based study ...

DOI: 10.1016/S1474-4422 (25)00199-1 Individual immune cells genetically altered CIDP is an autoimmune disease in which the immune system's B-cells attack the peripheral nervous system.

CIDP is an autoimmune disease in which the immune system's B-cells attack the peripheral nervous system. In the current study, the CAR CD19 T-cell therapy was used to combat these rogue B-cells.

Misbehaving T cells light up long before Parkinson’s symptoms show, zeroing in on vulnerable brain proteins. Their early ...

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare ...

People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or ...

Your brain and skin are interconnected—and when a disorder affects both, treatment must involve a multidisciplinary approach.

The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) subcutaneous (SC) injection to treat chronic ...

LJI scientists have discovered that T cells may help detect Parkinson's disease years before motor symptoms appear. Your T ...

Individual immune cells genetically altered CIDP is an autoimmune disease in which the immune system’s B-cells attack the peripheral nervous system. In the current study, the CAR CD19 T-cell therapy ...